New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
08:55 EDTCNAT, CNAT, CNAT, CNAT, CNAT, CNATConatus Pharmaceuticals management to meet with Roth Capital
Meetings to be held in Europe March 12-14 hosted by Roth Capital.
News For CNAT From The Last 14 Days
Check below for free stories on CNAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
16:21 EDTCNATConatus files $150M mixed securities shelf
Subscribe for More Information
10:53 EDTCNATHigh option volume stocks
Subscribe for More Information
August 13, 2014
18:55 EDTCNATOn The Fly: After Hours Movers
UP AFTER EARNINGS: Aspen Technology (AZPN), up almost 3% after reporting better than expected Q4 results and giving Q1 and FY15 guidance on its earnings conference call. ALSO HIGHER: Kindred Healthcare (KND), up more than 1% after Point72 reported a 5.1% passive stake in the company. DOWN AFTER EARNINGS: Cisco Systems (CSCO), down 1.2% after reporting Q4 results, giving Q1 guidance, and announcing that it is cutting 8% of its workforce... Noodles & Company (NDLS), down 21.2% after reporting Q2 results and "tempering" its FY14 outlook... Conatus Pharmaceuticals (CNAT), down 13.6% after reporting Q2 results and announcing it is deferring the results of its NAFLD/NASH clinical trial to 1Q15. ALSO LOWER: Amgen (AMGN), down 2.15% after announcing the Phase 3 Kyprolis FOCUS clinical trial did not meet its primary endpoint.
16:57 EDTCNATConatus Phase 2 NAFLD/NASH clinical trial results announcement deferred to 1Q15
Subscribe for More Information
16:05 EDTCNATConatus reports Q2 EPS (34c), consensus (40c)
Subscribe for More Information
August 12, 2014
10:15 EDTCNATIntercept surges after reporting data for liver disease drug OCA
Subscribe for More Information
09:21 EDTCNATOn The Fly: Pre-market Movers
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use